世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5234 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、鎌状赤血球貧血治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、薬物療法、骨髄移植）、用途別市場規模（子供用、大人用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鎌状赤血球貧血治療薬の市場動向 ・企業の競争状況、市場シェア ・鎌状赤血球貧血治療薬の種類別市場規模（輸血、薬物療法、骨髄移植） ・鎌状赤血球貧血治療薬の用途別市場規模（子供用、大人用） ・鎌状赤血球貧血治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・鎌状赤血球貧血治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鎌状赤血球貧血治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鎌状赤血球貧血治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・鎌状赤血球貧血治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Addmedica、Gamida Cell、GlycoMimetics、Pfizer、Novartis、Global Blood Therapeutics、Micelle BioPharma、Bluebird Bio、Prolong Pharmaceuticals、Modus Therapeutics、Sangamo Biosciences、Bioverativ、Imara、Ironwood Pharmaceuticals） ・結論

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13.32% during 2013 to 2017. In 2017, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.

Market Analysis and Insights: Global Sickle-cell Anemia Therapeutics Market
The global Sickle-cell Anemia Therapeutics market size is projected to reach US$ 4406.3 million by 2026, from US$ 1633.2 million in 2019, at a CAGR of 15.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sickle-cell Anemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sickle-cell Anemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sickle-cell Anemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sickle-cell Anemia Therapeutics market.

Global Sickle-cell Anemia Therapeutics Scope and Market Size
Sickle-cell Anemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle-cell Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant

Segment by Application
Child
Adult

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Pfizer
Novartis
Bioverativ

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by Application
1.3.1 Global Sickle-cell Anemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sickle-cell Anemia Therapeutics Market Perspective (2016-2027)
2.2 Sickle-cell Anemia Therapeutics Growth Trends by Regions
2.2.1 Sickle-cell Anemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle-cell Anemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Sickle-cell Anemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Sickle-cell Anemia Therapeutics Industry Dynamic
2.3.1 Sickle-cell Anemia Therapeutics Market Trends
2.3.2 Sickle-cell Anemia Therapeutics Market Drivers
2.3.3 Sickle-cell Anemia Therapeutics Market Challenges
2.3.4 Sickle-cell Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue
3.1.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Sickle-cell Anemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Sickle-cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle-cell Anemia Therapeutics Revenue
3.4 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle-cell Anemia Therapeutics Revenue in 2020
3.5 Sickle-cell Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Sickle-cell Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle-cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Sickle-cell Anemia Therapeutics Breakdown Data by Application
5.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sickle-cell Anemia Therapeutics Market Size (2016-2027)
6.2 North America Sickle-cell Anemia Therapeutics Market Size by Type
6.2.1 North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Sickle-cell Anemia Therapeutics Market Size by Application
6.3.1 North America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Sickle-cell Anemia Therapeutics Market Size by Country
6.4.1 North America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Sickle-cell Anemia Therapeutics Market Size (2016-2027)
7.2 Europe Sickle-cell Anemia Therapeutics Market Size by Type
7.2.1 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Sickle-cell Anemia Therapeutics Market Size by Application
7.3.1 Europe Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Sickle-cell Anemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Sickle-cell Anemia Therapeutics Market Size by Country
7.4.1 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sickle-cell Anemia Therapeutics Market Size (2016-2027)
9.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Type
9.2.1 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Application
9.3.1 Latin America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Sickle-cell Anemia Therapeutics Market Size by Country
9.4.1 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Addmedica
11.1.1 Addmedica Company Details
11.1.2 Addmedica Business Overview
11.1.3 Addmedica Sickle-cell Anemia Therapeutics Introduction
11.1.4 Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.1.5 Addmedica Recent Development
11.2 Gamida Cell
11.2.1 Gamida Cell Company Details
11.2.2 Gamida Cell Business Overview
11.2.3 Gamida Cell Sickle-cell Anemia Therapeutics Introduction
11.2.4 Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.2.5 Gamida Cell Recent Development
11.3 GlycoMimetics
11.3.1 GlycoMimetics Company Details
11.3.2 GlycoMimetics Business Overview
11.3.3 GlycoMimetics Sickle-cell Anemia Therapeutics Introduction
11.3.4 GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.3.5 GlycoMimetics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle-cell Anemia Therapeutics Introduction
11.4.4 Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Sickle-cell Anemia Therapeutics Introduction
11.5.4 Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Global Blood Therapeutics
11.6.1 Global Blood Therapeutics Company Details
11.6.2 Global Blood Therapeutics Business Overview
11.6.3 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.6.4 Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.6.5 Global Blood Therapeutics Recent Development
11.7 Micelle BioPharma
11.7.1 Micelle BioPharma Company Details
11.7.2 Micelle BioPharma Business Overview
11.7.3 Micelle BioPharma Sickle-cell Anemia Therapeutics Introduction
11.7.4 Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.7.5 Micelle BioPharma Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Sickle-cell Anemia Therapeutics Introduction
11.8.4 Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.8.5 Bluebird Bio Recent Development
11.9 Prolong Pharmaceuticals
11.9.1 Prolong Pharmaceuticals Company Details
11.9.2 Prolong Pharmaceuticals Business Overview
11.9.3 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.9.4 Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.9.5 Prolong Pharmaceuticals Recent Development
11.10 Modus Therapeutics
11.10.1 Modus Therapeutics Company Details
11.10.2 Modus Therapeutics Business Overview
11.10.3 Modus Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.10.4 Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.10.5 Modus Therapeutics Recent Development
11.11 Sangamo Biosciences
11.11.1 Sangamo Biosciences Company Details
11.11.2 Sangamo Biosciences Business Overview
11.11.3 Sangamo Biosciences Sickle-cell Anemia Therapeutics Introduction
11.11.4 Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.11.5 Sangamo Biosciences Recent Development
11.12 Bioverativ
11.12.1 Bioverativ Company Details
11.12.2 Bioverativ Business Overview
11.12.3 Bioverativ Sickle-cell Anemia Therapeutics Introduction
11.12.4 Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.12.5 Bioverativ Recent Development
11.13 Imara
11.13.1 Imara Company Details
11.13.2 Imara Business Overview
11.13.3 Imara Sickle-cell Anemia Therapeutics Introduction
11.13.4 Imara Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.13.5 Imara Recent Development
11.14 Ironwood Pharmaceuticals
11.14.1 Ironwood Pharmaceuticals Company Details
11.14.2 Ironwood Pharmaceuticals Business Overview
11.14.3 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.14.4 Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.14.5 Ironwood Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle-cell Anemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sickle-cell Anemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sickle-cell Anemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2022-2027)
Table 11. Sickle-cell Anemia Therapeutics Market Trends
Table 12. Sickle-cell Anemia Therapeutics Market Drivers
Table 13. Sickle-cell Anemia Therapeutics Market Challenges
Table 14. Sickle-cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle-cell Anemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sickle-cell Anemia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2020)
Table 18. Ranking of Global Top Sickle-cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sickle-cell Anemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Sickle-cell Anemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sickle-cell Anemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Addmedica Company Details
Table 63. Addmedica Business Overview
Table 64. Addmedica Sickle-cell Anemia Therapeutics Product
Table 65. Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Addmedica Recent Development
Table 67. Gamida Cell Company Details
Table 68. Gamida Cell Business Overview
Table 69. Gamida Cell Sickle-cell Anemia Therapeutics Product
Table 70. Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Gamida Cell Recent Development
Table 72. GlycoMimetics Company Details
Table 73. GlycoMimetics Business Overview
Table 74. GlycoMimetics Sickle-cell Anemia Therapeutics Product
Table 75. GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlycoMimetics Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Sickle-cell Anemia Therapeutics Product
Table 80. Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Sickle-cell Anemia Therapeutics Product
Table 85. Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Global Blood Therapeutics Company Details
Table 88. Global Blood Therapeutics Business Overview
Table 89. Global Blood Therapeutics Sickle-cell Anemia Therapeutics Product
Table 90. Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Global Blood Therapeutics Recent Development
Table 92. Micelle BioPharma Company Details
Table 93. Micelle BioPharma Business Overview
Table 94. Micelle BioPharma Sickle-cell Anemia Therapeutics Product
Table 95. Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Micelle BioPharma Recent Development
Table 97. Bluebird Bio Company Details
Table 98. Bluebird Bio Business Overview
Table 99. Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bluebird Bio Recent Development
Table 101. Prolong Pharmaceuticals Company Details
Table 102. Prolong Pharmaceuticals Business Overview
Table 103. Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 104. Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Prolong Pharmaceuticals Recent Development
Table 106. Modus Therapeutics Company Details
Table 107. Modus Therapeutics Business Overview
Table 108. Modus Therapeutics Sickle-cell Anemia Therapeutics Product
Table 109. Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Modus Therapeutics Recent Development
Table 111. Sangamo Biosciences Company Details
Table 112. Sangamo Biosciences Business Overview
Table 113. Sangamo Biosciences Sickle-cell Anemia Therapeutics Product
Table 114. Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Sangamo Biosciences Recent Development
Table 116. Bioverativ Company Details
Table 117. Bioverativ Business Overview
Table 118. Bioverativ Sickle-cell Anemia Therapeutics Product
Table 119. Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Bioverativ Recent Development
Table 121. Imara Company Details
Table 122. Imara Business Overview
Table 123. Imara Sickle-cell Anemia Therapeutics Product
Table 124. Imara Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Imara Recent Development
Table 126. Ironwood Pharmaceuticals Company Details
Table 127. Ironwood Pharmaceuticals Business Overview
Table 128. Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 129. Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 130. Ironwood Pharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle-cell Anemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Blood Transfusion Features
Figure 3. Pharmacotherapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Global Sickle-cell Anemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Child Case Studies
Figure 7. Adult Case Studies
Figure 8. Sickle-cell Anemia Therapeutics Report Years Considered
Figure 9. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sickle-cell Anemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Sickle-cell Anemia Therapeutics Market Share by Players in 2020
Figure 14. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Sickle-cell Anemia Therapeutics Revenue in 2020
Figure 16. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Sickle-cell Anemia Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Sickle-cell Anemia Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Region (2016-2027)
Figure 38. China Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Sickle-cell Anemia Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Addmedica Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 58. Gamida Cell Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 59. GlycoMimetics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 62. Global Blood Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 63. Micelle BioPharma Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 64. Bluebird Bio Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 65. Prolong Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 66. Modus Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 67. Sangamo Biosciences Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 68. Bioverativ Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 69. Imara Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 70. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---